Potential antitumor activity of novel DODAC/PHO-S liposomes

Código QR

Potential antitumor activity of novel DODAC/PHO-S liposomes

Arthur Cássio de Lima Luna,1,2 Greice Kelle Viegas Saraiva,3 Otaviano Mendonça Ribeiro Filho,4 Gilberto Orivaldo Chierice,5 Salvador Claro Neto,5 Iolanda Midea Cuccovia,3 Durvanei Augusto Maria1,2 1Biochemistry and Biophysical Laboratory, Butantan Institute, 2Department of Med...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Luna ACL, Saraiva GKV, Filho OMR, Chierice GO, Neto SC, Cuccovia IM, Maria DA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Hepatocellular carcinoma liposomes synthetic phosphoethanolamine tumor cells. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8b85249aca5a4712aba0e95f5937188d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
por: Zhang L, et al.
Publicado: (2021)

Liposome-Coated Arsenic–Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma
por: Jin Z, et al.
Publicado: (2021)

Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo
por: Luo YL, et al.
Publicado: (2016)

Journal of liposome research
Publicado: (1988)

Build-a-Cell: Engineering a Synthetic Cell Community
por: Caroline Frischmon, et al.
Publicado: (2021)

Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes
por: Feng Y, et al.
Publicado: (2021)

Hepatocarcinoma con invasión cardiovascular: comunicación de 5 casos y revisión de la literatura
por: Valera M,José M, et al.
Publicado: (2004)

Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
por: Wi TI, et al.
Publicado: (2020)

Hepatocarcinoma, porfiria y hemosiderosis. Una asociación no reportada en nuestro país: Caso clínico
por: WHITTLE,CAROLINA, et al.
Publicado: (2010)

Carcinoma hepatocelular variedad fibrolamelar metastásico en menores de 20 años: Reporte de 2 casos tratados con intención curativa y revisión de la literatura
por: Butte,Jean M, et al.
Publicado: (2009)

Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
por: Petrini M, et al.
Publicado: (2021)

A Combined Antitumor Strategy Mediated by a New Targeted Nanosystem to Hepatocellular Carcinoma
por: Farinha D, et al.
Publicado: (2021)

In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach
por: Al-Asmari AK, et al.
Publicado: (2017)

Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity
por: Gao L, et al.
Publicado: (2021)

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Rui Xing, et al.
Publicado: (2021)

Image-Guided BrachyAblation (IGBA) en hepatocarcinoma. Descripción de la técnica y reporte del primer caso en Chile
por: San Martín M.,Evelyn, et al.
Publicado: (2019)

Cryopreservation of horse semen with a liposome and trehalose added extender
por: Medina-León,Ariadna Z., et al.
Publicado: (2019)

Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
por: Ma C, et al.
Publicado: (2021)

Lipid-Binding Aegerolysin from Biocontrol Fungus <i>Beauveria bassiana</i>
por: Nada Kraševec, et al.
Publicado: (2021)

Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy
por: Gu Y, et al.
Publicado: (2019)

Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
por: Han B, et al.
Publicado: (2020)

Encapsulation of α-Pinene in Delivery Systems Based on Liposomes and Cyclodextrins
por: Zahraa Hammoud, et al.
Publicado: (2021)

Effects of the protein corona on liposome–liposome and liposome–cell interactions
por: Corbo C, et al.
Publicado: (2016)

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
por: Masatoshi Kudo
Publicado: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant <i>TP53</i> or Wild-Type <i>CTNNB1</i> Gene
por: Jiunn-Chang Lin, et al.
Publicado: (2021)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021)

Hematocele y hemoperitoneo como manifestación inicial de carcinoma hepatocelular: Caso clínico
por: Schiappacasse-Faúndes,Giancarlo, et al.
Publicado: (2021)

Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2
por: Al Refaey,Heba R., et al.
Publicado: (2021)

Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics
por: Omar MM, et al.
Publicado: (2021)

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
por: Kong L, et al.
Publicado: (2020)

Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo
por: Liu MC, et al.
Publicado: (2016)

Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
por: Amin M, et al.
Publicado: (2018)

Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
por: Christensen E, et al.
Publicado: (2018)

Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma
por: Mei Luo, et al.
Publicado: (2021)

Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018)

Hepatocarcinoma.: Descripción de características clínicas verificadas en una Región del sur de Chile
por: Manterola D,Carlos, et al.
Publicado: (2000)

Asociación entre polimorfismos de un nucleótido en microRNA circulante y riesgo de carcinoma hepatocelular
por: Li,Wenshuai, et al.
Publicado: (2016)